These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28594935)

  • 1. A nested case-control study of 277 prediagnostic serum cytokines and glioma.
    Schwartzbaum J; Wang M; Root E; Pietrzak M; Rempala GA; Huang RP; Johannesen TB; Grimsrud TK
    PLoS One; 2017; 12(6):e0178705. PubMed ID: 28594935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.
    Schwartzbaum J; Seweryn M; Holloman C; Harris R; Handelman SK; Rempala GA; Huang RP; Burkholder B; Brandemihl A; Kallberg H; Johannesen TB; Ahlbom A; Feychting M; Grimsrud TK
    PLoS One; 2015; 10(9):e0137503. PubMed ID: 26352148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.
    Zigmont V; Garrett A; Peng J; Seweryn M; Rempala GA; Harris R; Holloman C; Gundersen TE; Ahlbom A; Feychting M; Johannesen TB; Grimsrud TK; Schwartzbaum J
    Nutr Cancer; 2015; 67(7):1120-30. PubMed ID: 26317248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between prediagnostic IgE levels and risk of glioma.
    Schwartzbaum J; Ding B; Johannesen TB; Osnes LT; Karavodin L; Ahlbom A; Feychting M; Grimsrud TK
    J Natl Cancer Inst; 2012 Aug; 104(16):1251-9. PubMed ID: 22855780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serially measured pre-diagnostic levels of serum cytokines and risk of brain cancer in active component military personnel.
    Brenner AV; Inskip PD; Rusiecki J; Rabkin CS; Engels J; Pfeiffer RM
    Br J Cancer; 2018 Oct; 119(7):893-900. PubMed ID: 30297770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.
    Nijaguna MB; Patil V; Hegde AS; Chandramouli BA; Arivazhagan A; Santosh V; Somasundaram K
    PLoS One; 2015; 10(9):e0137524. PubMed ID: 26390214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study.
    Späth F; Andersson U; Dahlin AM; Langseth H; Hovig E; Johannesen TB; Grankvist K; Björkblom B; Wibom C; Melin B
    Tumour Biol; 2016 Aug; 37(8):11065-72. PubMed ID: 26906551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.
    Edlefsen KL; Martínez-Maza O; Madeleine MM; Magpantay L; Mirick DK; Kopecky KJ; LaCroix AZ; De Roos AJ
    Int J Cancer; 2014 Aug; 135(4):913-22. PubMed ID: 24488825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergy-related polymorphisms influence glioma status and serum IgE levels.
    Wiemels JL; Wiencke JK; Kelsey KT; Moghadassi M; Rice T; Urayama KY; Miike R; Wrensch M
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1229-35. PubMed ID: 17548690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma risk in relation to serum levels of insulin-like growth factors.
    Lönn S; Inskip PD; Pollak MN; Weinstein SJ; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):844-6. PubMed ID: 17416782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk.
    Schwartzbaum J; Jonsson F; Ahlbom A; Preston-Martin S; Malmer B; Lönn S; Söderberg K; Feychting M
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):643-50. PubMed ID: 15767344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition.
    Saberi Hosnijeh F; Krop EJ; Scoccianti C; Krogh V; Palli D; Panico S; Tumino R; Sacredote C; Nawroly N; Portengen L; Linseisen J; Vineis P; Vermeulen R
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1577-84. PubMed ID: 20501772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
    Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort.
    Schlehofer B; Siegmund B; Linseisen J; Schüz J; Rohrmann S; Becker S; Michaud D; Melin B; Bas Bueno-de-Mesquita H; Peeters PH; Vineis P; Tjonneland A; Olsen A; Overvad K; Romieu I; Boeing H; Aleksandrova K; Trichopoulou A; Bamia C; Lagiou P; Sacerdote C; Palli D; Panico S; Sieri S; Tumino R; Sanchez MJ; Rodriguez L; Dorronsoro M; Duell EJ; Chirlaque MD; Barricarte A; Borgquist S; Manjer J; Gallo V; Allen NE; Key TJ; Riboli E; Kaaks R; Wahrendorf J
    Allergy; 2011 Nov; 66(11):1434-41. PubMed ID: 21726235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk.
    Schwartzbaum JA; Ahlbom A; Lönn S; Malmer B; Wigertz A; Auvinen A; Brookes AJ; Collatz Christensen H; Henriksson R; Johansen C; Salminen T; Schoemaker MJ; Swerdlow AJ; Debinski W; Feychting M
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2448-54. PubMed ID: 18006935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and risk of glioma: a nationwide nested case-control study.
    Andersen L; Friis S; Hallas J; Ravn P; Gaist D
    Cancer Epidemiol; 2013 Dec; 37(6):876-80. PubMed ID: 24138870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic conditions and brain tumor risk.
    Wigertz A; Lönn S; Schwartzbaum J; Hall P; Auvinen A; Christensen HC; Johansen C; Klaeboe L; Salminen T; Schoemaker MJ; Swerdlow AJ; Tynes T; Feychting M
    Am J Epidemiol; 2007 Oct; 166(8):941-50. PubMed ID: 17646205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer in first-degree relatives and risk of glioma in adults.
    Hill DA; Inskip PD; Shapiro WR; Selker RG; Fine HA; Black PM; Linet MS
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1443-8. PubMed ID: 14693735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-diagnostic levels of sVEGFR2, sTNFR2, sIL-2Rα and sIL-6R are associated with glioma risk: A nested case-control study of repeated samples.
    Wu WY; Späth F; Wibom C; Björkblom B; Dahlin AM; Melin B
    Cancer Med; 2022 Feb; 11(4):1016-1025. PubMed ID: 35029050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.